Literature DB >> 23257376

Retrograde coronary chronic total occlusion revascularization: procedural and in-hospital outcomes from a multicenter registry in the United States.

Dimitri Karmpaliotis1, Tesfaldet T Michael, Emmanouil S Brilakis, Aristotelis C Papayannis, Daniel L Tran, Ben L Kirkland, Nicholas Lembo, Anna Kalynych, Harold Carlson, Subhash Banerjee, William Lombardi, David E Kandzari.   

Abstract

OBJECTIVES: This study sought to examine the contemporary outcomes of retrograde chronic total occlusion (CTO) interventions among 3 experienced U.S. centers.
BACKGROUND: The retrograde approach, pioneered and developed in Japan, has revolutionized the treatment of coronary CTO, yet limited information exists on procedural efficacy, safety, and reproducibility of outcomes in other settings.
METHODS: Between 2006 and 2011, 462 consecutive retrograde CTO interventions were performed at 3 U.S. institutions. Patient characteristics, procedural outcomes, and in-hospital clinical events were ascertained.
RESULTS: Mean patient age was 65 ± 9.7 years, 84% were men, and 50% had prior coronary artery bypass surgery. The CTO target vessel was the right coronary artery (66%), circumflex (18%), left anterior descending artery (15.5%), and left main artery or bypass graft (0.5%). The retrograde approach was used as the primary method in 46% of cases and after failed antegrade recanalization in 54%. Retrograde collateral vessels were septal (68%), epicardial (24%), and bypass grafts (8%). Technical and procedural success was 81.4% (n = 376) and 79.4% (n = 367), respectively. The mean contrast volume and fluoroscopy time were 345 ± 177 ml and 61 ± 40 min, respectively. A major complication occurred in 12 patients (2.6%). In multivariable analysis, years since initiation of retrograde CTO percutaneous coronary intervention (PCI) at each center, female sex, and ejection fraction ≥40% were associated with higher technical success.
CONCLUSIONS: Among selected U.S. programs, retrograde CTO PCI is often performed in patients with prior coronary bypass graft surgery and is associated with favorably high success and low complication rates.
Copyright © 2012 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23257376     DOI: 10.1016/j.jcin.2012.06.025

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  32 in total

1.  Temporal trends of fluoroscopy time and contrast utilization in coronary chronic total occlusion revascularization: insights from a multicenter United States registry.

Authors:  Tesfaldet T Michael; Dimitri Karmpaliotis; Emmanouil S Brilakis; Mohammed Alomar; Shuaib M Abdullah; Ben L Kirkland; Katrina L Mishoe; Nicholas Lembo; Anna Kalynych; Harold Carlson; Subhash Banerjee; Michael Luna; William Lombardi; David E Kandzari
Journal:  Catheter Cardiovasc Interv       Date:  2014-01-31       Impact factor: 2.692

Review 2.  Practical utilization of cardiac computed tomography for the success in complex coronary intervention.

Authors:  Kenji Sadamatsu; Masaaki Okutsu; Satoru Sumitsuji; Tomohiro Kawasaki; Sunao Nakamura; Yoshihiro Fukumoto; Kenichi Tsujita; Shinjo Sonoda; Yoshio Kobayashi; Yuji Ikari
Journal:  Cardiovasc Interv Ther       Date:  2021-01-11

Review 3.  Approach to CTO Intervention: Overview of Techniques.

Authors:  Aris Karatasakis; Barbara Anna Danek; Dimitri Karmpaliotis; Khaldoon Alaswad; Minh Vo; Mauro Carlino; Mitul P Patel; Stéphane Rinfret; Emmanouil S Brilakis
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-01

4.  Application and outcomes of a hybrid approach to chronic total occlusion percutaneous coronary intervention in a contemporary multicenter US registry.

Authors:  Georgios Christopoulos; Dimitri Karmpaliotis; Khaldoon Alaswad; Robert W Yeh; Farouc A Jaffer; R Michael Wyman; William L Lombardi; Rohan V Menon; J Aaron Grantham; David E Kandzari; Nicholas Lembo; Jeffrey W Moses; Ajay J Kirtane; Manish Parikh; Philip Green; Matthew Finn; Santiago Garcia; Anthony Doing; Mitul Patel; John Bahadorani; Muhammad Nauman J Tarar; Georgios E Christakopoulos; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Int J Cardiol       Date:  2015-06-27       Impact factor: 4.164

Review 5.  Advances in the management of coronary chronic total occlusions.

Authors:  Emmanouil S Brilakis; Dimitri Karmpaliotis; Minh N Vo; Santiago Garcia; Lampros Michalis; Khaldoon Alaswad; Parag Doshi; William L Lombardi; Subhash Banerjee
Journal:  J Cardiovasc Transl Res       Date:  2014-03-15       Impact factor: 4.132

6.  Periprocedural myocardial injury in chronic total occlusion percutaneous interventions: a systematic cardiac biomarker evaluation study.

Authors:  Nathan Lo; Tesfaldet T Michael; Danyaal Moin; Vishal G Patel; Mohammed Alomar; Aristotelis Papayannis; Daisha Cipher; Shuaib M Abdullah; Subhash Banerjee; Emmanouil S Brilakis
Journal:  JACC Cardiovasc Interv       Date:  2013-12-11       Impact factor: 11.195

7.  Does the hybrid algorithm has real impact on long-term outcomes or should only be used as a valuable approach for CTO crossing?

Authors:  Peter Tajti; Emmanouil S Brilakis
Journal:  J Thorac Dis       Date:  2018-03       Impact factor: 2.895

8.  Intravascular Ultrasound Analysis of Intraplaque Versus Subintimal Tracking in Percutaneous Intervention for Coronary Chronic Total Occlusions and Association With Procedural Outcomes.

Authors:  Lei Song; Akiko Maehara; Matthew T Finn; Sanjog Kalra; Jeffrey W Moses; Manish A Parikh; Ajay J Kirtane; Michael B Collins; Tamim M Nazif; Khady N Fall; Raja Hatem; Ming Liao; Tiffany Kim; Philip Green; Ziad A Ali; Candido Batres; Martin B Leon; Gary S Mintz; Dimitri Karmpaliotis
Journal:  JACC Cardiovasc Interv       Date:  2017-05-22       Impact factor: 11.195

Review 9.  Chronic total occlusions: patient selection and overview of advanced techniques.

Authors:  Santiago Garcia; Shuaib Abdullah; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Curr Cardiol Rep       Date:  2013-02       Impact factor: 2.931

10.  [Not Available].

Authors:  Chiu-Fen Yang; Michael Y Chen; Mei-Ling Chen; Ji-Hung Wang
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.